BAM
Blueshift Asset Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,067
| Closed | -$239K | – | 621 |
|
|
2025
Q1 | $239K | Buy |
+1,067
| New | +$239K | 0.09% | 316 |
|
|
2024
Q3 | – | Sell |
-1,001
| Closed | -$330K | – | 487 |
|
|
2024
Q2 | $330K | Buy |
1,001
+467
| +87% | +$154K | 0.11% | 228 |
|
|
2024
Q1 | $211K | Sell |
534
-1,265
| -70% | -$501K | 0.11% | 251 |
|
|
2023
Q4 | $633K | Buy |
1,799
+1,178
| +190% | +$415K | 0.34% | 81 |
|
|
2023
Q3 | $233K | Buy |
+621
| New | +$233K | 0.14% | 228 |
|
|
2023
Q1 | – | Sell |
-2,277
| Closed | -$536K | – | 475 |
|
|
2022
Q4 | $536K | Sell |
2,277
-916
| -29% | -$216K | 0.25% | 111 |
|
|
2022
Q3 | $786K | Sell |
3,193
-2,908
| -48% | -$716K | 0.17% | 176 |
|
|
2022
Q2 | $1.85M | Buy |
+6,101
| New | +$1.85M | 0.3% | 82 |
|
|
2021
Q4 | – | Sell |
-15,314
| Closed | -$6.5M | – | 1265 |
|
|
2021
Q3 | $6.5M | Buy |
15,314
+7,412
| +94% | +$3.15M | 0.36% | 55 |
|
|
2021
Q2 | $2.84M | Buy |
+7,902
| New | +$2.84M | 0.16% | 164 |
|
|
2021
Q1 | – | Sell |
-2,685
| Closed | -$761K | – | 1103 |
|
|
2020
Q4 | $761K | Buy |
+2,685
| New | +$761K | 0.09% | 319 |
|
|
2020
Q3 | – | Sell |
-8,783
| Closed | -$2M | – | 794 |
|
|
2020
Q2 | $2M | Buy |
+8,783
| New | +$2M | 0.32% | 93 |
|
|
2019
Q2 | – | Sell |
-9,282
| Closed | -$1.02M | – | 992 |
|
|
2019
Q1 | $1.02M | Buy |
+9,282
| New | +$1.02M | 0.14% | 236 |
|